# Protected Carotid Artery Stenting in Subjects at High Risk for Carotid Endarterectomy (CEA) (PROTECT)

> **NCT00402740** · NA · COMPLETED · sponsor: **Abbott Medical Devices** · enrollment: 322 (actual)

## Conditions studied

- Carotid Artery Disease

## Interventions

- **DEVICE:** Xact Stent with either Emboshield Pro (Gen 5) or Emboshield (Gen 3)

## Key facts

- **NCT ID:** NCT00402740
- **Lead sponsor:** Abbott Medical Devices
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-11
- **Primary completion:** 2011-06
- **Final completion:** 2011-10
- **Target enrollment:** 322 (ACTUAL)
- **Last updated:** 2012-06-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00402740

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00402740, "Protected Carotid Artery Stenting in Subjects at High Risk for Carotid Endarterectomy (CEA) (PROTECT)". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00402740. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*